Literature DB >> 12583840

Neurologic aspects of HIV infection in infants and children: therapeutic approaches and outcome.

Lucy Civitello1.   

Abstract

Central nervous system (CNS) HIV-related disorders frequently have devastating consequences. Significant progress has been made in the early diagnosis and treatment of the HIV-infected patient. As a result, the prevalence and natural history of neurologic illnesses have changed. This paper reviews the epidemiology, clinical manifestations, and neuropathogenesis of HIV-related CNS disorders. Advances in antiretroviral therapy, neuroprophylaxis, and neuroprotective strategies are also discussed.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12583840     DOI： 10.1007/s11910-003-0063-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


  99 in total

1.  Prednisone improves human immunodeficiency virus encephalopathy in children.

Authors:  E R Stiehm; Y J Bryson; L M Frenkel; C M Szelc; S Gillespie; M E Williams; J M Watkins
Journal:  Pediatr Infect Dis J       Date:  1992-01       Impact factor: 2.129

2.  Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir.

Authors:  G Pialoux; S Fournier; A Moulignier; J D Poveda; F Clavel; B Dupont
Journal:  AIDS       Date:  1997-08       Impact factor: 4.177

3.  Guidelines for the use of antiretroviral agents in pediatric HIV infection. Center for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-04-17

4.  Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism.

Authors:  J M Strizki; A V Albright; H Sheng; M O'Connor; L Perrin; F González-Scarano
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.

Authors:  O Bagasra; E Lavi; L Bobroski; K Khalili; J P Pestaner; R Tawadros; R J Pomerantz
Journal:  AIDS       Date:  1996-06       Impact factor: 4.177

6.  Evaluation of life quality for children infected by HIV: validation of a method and preliminary results.

Authors:  J Nicolas; A Dazord; S Manificat
Journal:  Pediatr AIDS HIV Infect       Date:  1996-08

Review 7.  Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species.

Authors:  S A Lipton
Journal:  Brain Pathol       Date:  1996-10       Impact factor: 6.508

8.  Interrelations among patterns of change in neurocognitive, CT brain imaging and CD4 measures associated with anti-retroviral therapy in children with symptomatic HIV infection.

Authors:  P Brouwers; C DeCarli; G Tudor-Williams; L Civitello; H Moss; P Pizzo
Journal:  Adv Neuroimmunol       Date:  1994

9.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection.

Authors:  L E Davis; B L Hjelle; V E Miller; D L Palmer; A L Llewellyn; T L Merlin; S A Young; R G Mills; W Wachsman; C A Wiley
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

10.  Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease.

Authors:  M I Bukrinsky; H S Nottet; H Schmidtmayerova; L Dubrovsky; C R Flanagan; M E Mullins; S A Lipton; H E Gendelman
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307
View more
  1 in total

Review 1.  Youths and HIV/AIDS: psychiatry's role in a changing epidemic.

Authors:  Geri R Donenberg; Maryland Pao
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-08       Impact factor: 8.829
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.